NDC 51662-1631 – Adenosine

Adenosine 3 mg/mL · Injection · Intravenous

Human Prescription Drug

Product NDC51662-1631

Product details

Brand name
Adenosine
Generic name
Adenosine
Labeler
HF Acquisition Co LLC, DBA HealthFirst
Dosage form
Injection
Route
Intravenous
Marketing category
ANDA · ANDA078686
Marketed since
April 28, 2023
Listing expires
December 31, 2026
Pharmacologic class
Adenosine Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Adenosine →

Package NDC codes (1)

Package NDCDescriptionSince
51662-1631-12 mL in 1 VIAL, SINGLE-DOSE (51662-1631-1)Apr 28, 2023

Other Adenosine products